Anaphore scoops up Chinese biotech; Clovis reveals $75M offering;

Tools

 @FierceBiotech: Researchers at the University of Bonn coaxed immature brain stem cells from mouse connective tissue. Story | Follow @FierceBiotech

 @JohnCFierce: Interesting piece from @reutersBenHir assessing all the problems with depression drugs. More | Follow @JohnCFierce

 @RyanMFierce: Who likes Durata Therapeutics' chances of pulling off an IPO? Release | Follow @RyanMFierce

@MarkHFierce: So there might be a genetic reason for chronic diarrhea, via MedPageToday. Story | Follow @MarkHFierce

> La Jolla, CA-based biotech Anaphore said that it has acquired Shanghai-based RuiTi, which specializes in discovering biologics that target G-protein coupled receptors. Release

> Boulder, CO-based cancer drug developer Clovis Oncology ($CLVS) has announced plans for a $75 million public offering. Report

> Paris-based Enterome, which specializes in biomarker discovery, has raised $6.6 million in a Series A round of funding. Report

Pharma News

 @FiercePharma: Shire chairman took home £8.5m. Article via @Guardian | Follow @FiercePharma

> Meet the new publisher of FiercePharma. More

> FDA seeks advice on making more drugs OTC. Story

> GlaxoSmithKline undeterred by spotty results for Relovair. Item

> EMA OKs Byetta for expanded treatment. News

> British Medical Journal focuses on questionable patent extension. Article

And Finally… Struggling AstraZeneca ($AZN) might be in the market to acquire U.S. drugmaker Forest Laboratories ($FRX). Item